Fineotex Chemical Sets Q2 FY27 Results Board Meeting for Nov 13

Fineotex Chemical Limited will consider Q2 FY27 results on November 13, 2026, after reporting Q1 FY27 net sales of ₹376.63 crore. The board-meeting notice, filed with the NSE on November 5, covers unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026.

When will Fineotex Chemical announce Q2 FY27 results?

Fineotex Chemical will consider and approve its unaudited Q2 FY27 and H1 FY27 financial results at a board meeting on Friday, November 13, 2026. The company disclosed the meeting schedule through its November 5 exchange filing, which also stated that the results would cover both standalone and consolidated financial statements.

The September-quarter period runs from July 1 to September 30, 2026. At the time of the board-meeting announcement, the company had not disclosed reported revenue, profit, margins or other financial details for Q2 FY27. As a result, figures from the June 2026 quarter remain the latest reported reference point until the September-quarter filing is released.

The company had earlier reported Q1 FY27 results on July 23, 2026. Its board-meeting intimation also noted that the trading window would remain closed, in line with the process followed ahead of the release of unpublished price-sensitive information.

What did Fineotex Chemical report in Q1 FY27?

Fineotex Chemical reported net sales turnover of ₹376.63 crore in Q1 FY27, compared with ₹137.07 crore in Q1 FY26 and ₹313.73 crore in Q4 FY26. The June-quarter sales figure represented year-on-year growth of about 175% and sequential growth of about 20% based on the reported quarterly data.

Reported profit for the year stood at ₹48.21 crore in Q1 FY27, versus ₹25.03 crore a year earlier and ₹43.79 crore in the March 2026 quarter. The quarterly results page also showed operating profit of ₹59.14 crore, EBITDA of ₹69.23 crore and EBIT of ₹64.84 crore for the June 2026 quarter.

These reported figures provide the immediate comparison base for investors assessing the forthcoming Q2 result. They do not indicate the September-quarter outcome, which will be known only when the company files the approved results with the exchanges.

Which Q2 FY27 benchmarks will investors monitor?

Investors will compare Fineotex Chemical's Q2 FY27 financial performance with the ₹137.71 crore net sales turnover and ₹26.08 crore reported profit recorded in Q2 FY26, the September 2025 quarter. This year-earlier base is relevant for measuring annual changes in revenue and profitability when the September 2026 numbers are published.

The sequential comparison will be against Q1 FY27, when net sales turnover was ₹376.63 crore and reported profit was ₹48.21 crore. The company’s reported sales had risen from ₹137.07 crore in June 2025 to ₹376.63 crore in June 2026, while reported profit increased from ₹25.03 crore to ₹48.21 crore over the same period.

Investors will also be able to review operating profit, EBITDA and EBIT alongside net profit. The company’s disclosed Q1 FY27 operating profit was ₹59.14 crore, while EBITDA was ₹69.23 crore. The reported financial statements and accompanying notes will provide the basis for understanding changes between the June and September quarters.

What happens after Fineotex Chemical's board meeting?

Fineotex Chemical has scheduled a virtual earnings conference call for November 16, 2026, at 11:00 AM IST to discuss Q2 and H1 FY27 operational and financial performance. The call is expected to involve senior executives, including the Executive Director, CFO, CEO, and the Head of M&A and Investor Relations.

The conference call follows the planned board consideration of the quarterly results and gives shareholders and market participants an opportunity to hear management’s discussion of the reported financial performance. The company has described the call as covering both the Q2 FY27 quarter and the first half of FY27.

For investors, the sequence of the results filing followed by the management call is important because the filed financial statement will establish the reported numbers, while the call may provide management commentary on operations and the period under review. Neither the board-meeting notice nor the call announcement provides an estimate for Q2 FY27 revenue or profit.

Why does the Q2 FY27 filing matter for investors?

Fineotex Chemical's Q2 filing matters because it will provide the first reported financial update for the July-September 2026 period and complete the first-half FY27 picture. The Q1 release showed a substantial rise in sales and reported profit from the corresponding quarter a year earlier, making the September result important for comparing the company’s latest performance with both Q1 FY27 and Q2 FY26.

The filing will also clarify whether the June-quarter level of sales, operating profit and reported profit was maintained, increased or reduced during the following quarter. Until the exchange filing is available, any circulating September-quarter revenue, profit or margin figure is not a reported company result and should not be treated as confirmed financial data.

Conclusion

Fineotex Chemical has formally scheduled its Q2 FY27 results board meeting for November 13, 2026, with the announcement covering unaudited standalone and consolidated results for the quarter and half year ended September 30. The latest reported financial reference is Q1 FY27, when net sales turnover stood at ₹376.63 crore and reported PAT was ₹48.21 crore.

The next disclosures to watch are the exchange filing following the board meeting and the virtual earnings call on November 16 at 11:00 AM IST. Investors can then compare reported Q2 FY27 sales, operating metrics and profit with the September 2025 quarter and the June 2026 quarter.